Learn More
Medchemexpress LLC 5-(4-butoxy-3-chlorophenyl)-N-((2-morpholinopyridin-3-yl)methyl)nicotinamide | 1266212-81-0 | 99.1% | 480.99 | C26H29ClN4O3 | 25 MG

Supplier: Medchemexpress LLC HY10008025MG
A-887826 is a potent, selective, voltage-dependent small-molecule blocker of the NaV1.8 (hNav1.8) sodium channel. Reported in peer-reviewed studies to block recombinant human NaV1.8 with an IC50 of ~11 nM, it is described as orally bioavailable and reduces neuropathic tactile allodynia in animal models. The compound is a nicotinamide/pyridine derivative (CAS 1266212-81-0).
- Potent NaV1.8 inhibition (IC50 ≈ 11 nM).
- Selective, voltage-dependent channel block.
- Orally bioavailable in reported studies.
- Demonstrated efficacy in neuropathic pain models.
- Well-characterized chemical identity and CAS registration.
- High reported purity (≈99.1%).
- Molecular weight 480.99 and formula C26H29ClN4O3.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.